AstraZeneca Appoints Iskra Reic as New International Chief Amid Chinese Probe

Iskra Reic has taken on the role of Executive Vice President for International Operations at AstraZeneca, stepping in amid an ongoing investigation involving her predecessor, Leon Wang, in China[1][2]. With experience spanning over two decades at AstraZeneca, Reic is set to oversee strategic operations across diverse regions, including China, Asia, Eurasia, Africa, Latin America, Australia, New Zealand, and the Middle East[2]. Her appointment comes as AstraZeneca seeks to continue its growth trajectory in international markets, despite the challenges posed by the investigation in China, with Reic praised by CEO Pascal Soriot as a leader capable of advancing AstraZeneca's global reach[1][2].